13F 机构持仓

BML Capital Management, LLC

ZIONSVILLE IN · SEC CIK 0001616824

2026Q22026Q1 更早 9 个季度 🔒
$1.76亿2026Q2 申报市值
18持仓数
93.3%前十大占比 · 第一大 36.0%
2 / 1新建仓 / 清仓
申报市值走势$1.76亿2026Q2
26Q126Q2

付费方案可看全部 11 个季度的走势 🔒

前十大持仓 占组合比例

ACRS 36.0%
AVIR 18.4%
ENGENE THERAPE 6.6%
KHC 6.2%
OUTSET MED INC 6.2%
KMX 5.2%
TILLYS INC 5.1%
PMV PHARMACEUT 4.1%
INSTIL BIO INC 2.8%
TGT 2.8%

2026Q2 买入最多 按季末市值估算

ENGENE THERAPEUT 新建仓+$1,153.89万
KHC 加仓+$803.08万
OUTSET MED INC 加仓+$266.76万
KMX 加仓+$92.56万
CONNECT BIOPHARM 加仓+$39.13万

2026Q2 卖出最多 按季末市值估算

ACRS 减仓-$1,203.47万
ORAMED PHARMACEU 减仓-$1,106.76万
KEZAR LIFE SCIEN 清仓-$534.82万
AVIR 减仓-$49.44万

2026Q2 持仓明细 点表头排序

导出 CSV 🔒
代码名称市值 ▲占比股数变动股数变动估算买卖额操作
— KEZAR LIFE SCIENCES INC $00.00%0 -720,787-100.0% -$534.82万 清仓
TSLA TESLA INC 看跌期权 $27.00万0.15%375 -625-62.5% -$45.00万 重新持有
CORZ CORE SCIENTIFIC INC NEW 看跌期权 $29.80万0.17%800 800— $29.80万 新建仓
WMT WALMART INC 看跌期权 $38.61万0.22%335 00.0% — 不变
— IMAGENEBIO INC $118.43万0.67%200,730 00.0% — 不变
— CONNECT BIOPHARMA HLDGS LTD $136.44万0.78%573,287 164,40040.2% $39.13万 加仓
— PLIANT THERAPEUTICS INC $176.26万1.00%1,546,137 00.0% — 不变
JANX JANUX THERAPEUTICS INC $238.02万1.35%154,961 00.0% — 不变
— ORAMED PHARMACEUTICALS INC $416.68万2.37%866,269 -2,300,962-72.6% -$1,106.76万 减仓
TGT TARGET CORP $489.79万2.78%37,500 00.0% — 不变
— INSTIL BIO INC $496.47万2.82%645,600 00.0% — 不变
— PMV PHARMACEUTICALS INC $714.22万4.06%5,330,000 10,0000.2% $1.34万 加仓
— TILLYS INC $903.00万5.13%2,150,000 00.0% — 不变
KMX CARMAX INC $912.35万5.18%172,500 17,50011.3% $92.56万 加仓
— OUTSET MED INC $1,088.51万6.18%2,519,701 617,50032.5% $266.76万 加仓
KHC KRAFT HEINZ CO $1,098.33万6.24%465,000 340,000272.0% $803.08万 加仓
— ENGENE THERAPEUTICS INC $1,153.89万6.55%6,669,908 6,669,908— $1,153.89万 新建仓
AVIR ATEA PHARMACEUTICALS INC $3,232.83万18.36%6,952,330 -106,327-1.5% -$49.44万 减仓
ACRS ACLARIS THERAPEUTICS INC $6,334.77万35.98%11,975,000 -2,275,000-16.0% -$1,203.47万 减仓